Kazia Financial Statements From 2010 to 2025
| KZIA Stock | USD 7.57 0.43 5.37% |
Gross Profit | Market Capitalization | Enterprise Value Revenue 3.1 K | Revenue | Earnings Share (12.67) |
Kazia Therapeutics Total Revenue |
|
Check Kazia Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kazia Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 2.3 K or Selling General Administrative of 8.6 M, as well as many indicators such as Price To Sales Ratio of 2.89, Dividend Yield of 0.0 or Days Sales Outstanding of 17.98. Kazia financial statements analysis is a perfect complement when working with Kazia Therapeutics Valuation or Volatility modules.
Kazia | Select Account or Indicator | Build AI portfolio with Kazia Stock |
Kazia Therapeutics Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kazia Therapeutics Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kazia Therapeutics Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kazia Therapeutics Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kazia Fundamental Market Drivers
Kazia Upcoming Events
| 4th of January 2024 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 29th of August 2024 Next Fiscal Year End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
About Kazia Therapeutics Financial Statements
Kazia Therapeutics stakeholders use historical fundamental indicators, such as Kazia Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Kazia Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Kazia Therapeutics' assets and liabilities are reflected in the revenues and expenses on Kazia Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Kazia Therapeutics Ltd. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -1.6 M | -1.5 M | |
| Total Revenue | 42 K | 39.9 K | |
| Stock Based Compensation To Revenue | 0.21 | 0.20 | |
| Sales General And Administrative To Revenue | 5.29 | 5.02 | |
| Research And Ddevelopement To Revenue | 6.78 | 6.44 | |
| Revenue Per Share | 5.53 | 5.26 | |
| Ebit Per Revenue | (14.18) | (14.89) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kazia Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kazia Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kazia Therapeutics Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kazia Therapeutics Ltd Stock:Check out the analysis of Kazia Therapeutics Correlation against competitors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kazia Therapeutics. If investors know Kazia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kazia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.67) | Revenue Per Share | Quarterly Revenue Growth (0.27) | Return On Assets | Return On Equity |
The market value of Kazia Therapeutics is measured differently than its book value, which is the value of Kazia that is recorded on the company's balance sheet. Investors also form their own opinion of Kazia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Kazia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kazia Therapeutics' market value can be influenced by many factors that don't directly affect Kazia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kazia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kazia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kazia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.